PRKCE and early-onset autosomal dominant Alzheimer disease: Preliminary animal studies support the role of PKCε in Alzheimer's disease, since PKCε activation in a transgenic mouse strain containing familial AD mutations was found to prevent amyloid plaques, synaptic loss and cognitive deficits [18].